When a breast cancer cell line variant was selected in vivo for increased metastatic capacity for bone, genotypic analysis revealed the upregulation of many genes relative to those expressed by an adrenal medulla seeking variant of the same cell line, including CXCR4, fibroblast growth factor-5 (FGF-5), connective tissue-derived growth factor, interleukin-11 (IL-11), and matrix metalloproteinase 1 (MMP1). This evidence concerns the gene MMP1 and breast carcinoma.